News
06-17-2010, 03:52 AM
Bayer Schering Pharma AG and OncoMed Pharmaceuticals, Inc., today announced a global strategic alliance to discover, develop and commercialize novel anti-cancer stem cell therapeutics targeting the Wnt signaling pathway.
More... (http://www.news-medical.net/news/20100617/Bayer-OncoMed-collaborate-to-develop-anti-cancer-stem-cell-therapeutics-to-target-Wnt-signaling-pathway.aspx)
More... (http://www.news-medical.net/news/20100617/Bayer-OncoMed-collaborate-to-develop-anti-cancer-stem-cell-therapeutics-to-target-Wnt-signaling-pathway.aspx)